Share. Connect. Create. Grow. · Socialiya
Replimune’s twice-rejected melanoma drug prevails in FDA adcomm

Following a pair of FDA rejections of its melanoma drug, Replimune's fortunes flipped today after an...

BUSINESS NEWS July 30, 2026

Replimune’s twice-rejected melanoma drug prevails in FDA adcomm

Following a pair of FDA rejections of its melanoma drug, Replimune's fortunes flipped today after an advisory committee voted 10 to 3 in favor of the...

12 views 0 likes 0 comments
Share:
Following a pair of FDA rejections of its melanoma drug, Replimune's fortunes flipped today after an advisory committee voted 10 to 3 in favor of the...

Author: Fierce Biotech

Read Original Article

Related News

Latest News

Advertisement

Top Categories

Advertisement
Advertisement
Advertisement
Advertisement